Dinesh V Ph D Patel
CEO, President at Protagonist Therapeutics, Inc (PTGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $60.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 10SEC | PTGXProtagonist Therapeutics, Inc | Sell Plan | 54,174522,968 held (−9%) | $145.87 | $7.9M | -1.5% |
| Sep 10SEC | PTGXProtagonist Therapeutics, Inc | Sell Plan | 63,548522,968 held (−11%) | $146.18 | $9.3M | -1.7% |
| Sep 10SEC | PTGXProtagonist Therapeutics, Inc | Sell Plan | 7,278522,968 held (−1%) | $144.10 | $1.0M | -0.3% |
| Aug 12SEC | PTGXProtagonist Therapeutics, Inc | Sell Plan | 65,761523,478 held (−11%) | $149.11 | $9.8M | -3.6% |
| Aug 12SEC | PTGXProtagonist Therapeutics, Inc | Sell Plan | 34,239523,478 held (−6%) | $148.52 | $5.1M | -3.2% |
| May 14SEC | PTGXProtagonist Therapeutics, Inc | Sell Plan | 75,000523,478 held (−13%) | $100.12 | $7.5M | +43.6% |
| May 12SEC | PTGXProtagonist Therapeutics, Inc | Sell | 75,000523,478 held (−13%) | $100.12 | $7.5M | +43.6% |
| Mar 25SEC | PTGXProtagonist Therapeutics, Inc | Sell | 59524,938 held (−0%) | $101.00 | $6K | +42.3% |
| Mar 25SEC | PTGXProtagonist Therapeutics, Inc | Sell | 54,641524,938 held (−9%) | $101.00 | $5.5M | +42.3% |
| Jan 27SEC | PTGXProtagonist Therapeutics, Inc | Sell | 19,315574,505 held (−3%) | $84.59 | $1.6M | +69.9% |
| Jan 27SEC | PTGXProtagonist Therapeutics, Inc | Sell | 10,685574,505 held (−2%) | $84.00 | $898K | +71.1% |
| Jan 27SEC | PTGXProtagonist Therapeutics, Inc | Sell | 14,205574,505 held (−2%) | $84.05 | $1.2M | +71.0% |
| Jan 27SEC | PTGXProtagonist Therapeutics, Inc | Sell | 4,068574,505 held (−1%) | $83.19 | $338K | +72.8% |
| Jan 21SEC | PTGXProtagonist Therapeutics, Inc | Sell | 34,438580,505 held (−6%) | $82.48 | $2.8M | +74.3% |
- Sell
CEO, President Dinesh V Ph D Patel sold $7.9M of PTGX at $145.87 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Dinesh V Ph D Patel sold $9.3M of PTGX at $146.18 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Dinesh V Ph D Patel sold $1.0M of PTGX at $144.10 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Dinesh V Ph D Patel sold $9.8M of PTGX at $149.11 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Dinesh V Ph D Patel sold $5.1M of PTGX at $148.52 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Dinesh V Ph D Patel sold $7.5M of PTGX at $100.12 — pre-scheduled 10b5-1 plan sale.